Dr. Paul Weinstein has spent over 40 years caring for patients with cancer and blood disorders at Stamford Health. He specializes in treating breast, lung and colon cancer.
Dr. Weinstein first received his training in hematology before joining the growing field of oncology. In 1986, he was awarded the Ettinger Fellowship Award from the Fairfield County Chapter American Cancer Society to study bone marrow transplants.
Dr. Weinstein enjoys taking care of patients and finds it rewarding to provide high-quality care. He is dedicated to his patients, partnering with them to develop personalized treatment plans. He uses all the resources available, including the numerous clinical trials and robust research at Stamford Health, to help each patient achieve his or her treatment goals.
As Medical Director of Medical Oncology and Hematology at Bennett Cancer Center, he leads Stamford Health medical oncologists and strives to improve the quality of cancer care. Through the center’s affiliations with the Dana Farber Brigham and Women’s Cancer Care Collaborative, he helps bring the most advanced cancer care to patients at Stamford Health.
As co-director of the Cancer Risk and Prevention program, he also helps patients and their families understand their genetic risks for cancer. Based on their genetic test results, he helps families develop plans to prevent cancer or detect cancer in early stages.
Dr. Weinstein enjoys working with all his colleagues at Stamford Health in an excellent environment where excellent people do excellent things.
Weinstein, P.L. et al. Unusual Cardiac Reaction to Chemotherapy Following Mediastinal Irradiation in Patients with Hodgkin's Disease. Am. J. Med. 60:152. 1976.
Cook, J.; Friedman, M.; Weinstein, P.L. Iron Supplements: Which Patient Really Needs Iron? Patient Care. 10:72, 1976.
Baranetsky, N.G.; Weinstein, P.L. Partial Thromboplastin Time for Screening. Ann Int. Med. 9l:498. 1979.
Arlin, Zalmen A.; Ahmed, Tauseef; Mittleman, Abraham; Feldman, Eric; Mehta, Rakesh; Weinstein, Paul L.; Rieber, Egmond; Sullivan, Phyllis; and Baskind, Paul. A New Regimen of Amsacrine With High Dose Cytarabine Is Safe and Effective Therapy for Acute Leukemia. Journal of Clinical Oncology. Vol. 5, No. 3. March, 1987. pp 371 375.
Shattuck-Eidens D, Oliphant A, McClure M, McBride C, Gupte J, Rubano T, Pruss D, Tavtigian SV, Teng D H-F, Adey N, Staebell M, Gumpper K, Lundstrom R, Hulick M, Kelly M, Holmen J, Lingenfelter B, Manley S, Fujimura F, Luce M, Ward B, Cannon-Albright L, Steele L, Offit K, Gilewski T, Norton L, Brown K, Schulz C, Hampel H, Schluger A, Giulotto E, Zoli W, Ravaioli A, Nevanlinna H, Pyrhonen S, Rowley P, Loader S, Osborne MP, Daly M, Tepler I, Weinstein PL, Scalia JL, Michaelson R, Scott RJ, Radice P, Pierotti MA, Garber JE, Isaacs C, Peshkin B, Lippman ME, Dosik MH, Caligo MA, Greenstein RM, Pilarski R, Weber B, Burgemeister R, Frank TS, Skolnick MH, Thomas A. BRCA1 sequence analysis in women at high risk for susceptibility mutations: risk factor analysis and implications for genetic testing. JAMA. 278:1242-1250. 1997.
Salvatore A. Del Prete, M.D., Scott P. Ryan, Judith S. Jacobson, DR.PH, Robert B. Erichson, M.D., Paul L. Weinstein, M.D., and Victor R. Grann, M.D. Safety and Costs of Treating Neutropenic Fever in an Outpatient Setting. Connecticut Medicine. Volume 63, No. 12; 713:717. December 1999.
K.M. Steve Lo, M. Beer, A. Conkling, P. Kosonen, V.R. Grann, R.B. Erichson, P.L. Weinstein, S.A. Del Prete, N.S. Cohen, D. Xistris, M.H. Bar. Paclitaxel (TXL) + Cyclophosphamide (CTX) + G-CSF and Etoposide (VP) + CTX + G-CSF are Similar in Their Ability to Mobilize Peripheral Blood Progenitor Cell (PBCS) in Patients with Breast Cancer Undergoing High Dose Chemotherapy (HDC). Blood. 1995. Vol. 86, NO 10: Suppl 1: 986a [Abstract 3934].
S. Ryan, S. DelPrete, P. Weinstein, R. Erichson, M. Bar, S. Lo, N. Cohen, I. Tepler: Low-Dose Vincristine-Associated Bilateral Vocal Cord Paralysis. Connecticut Medicine. October 1999. Vol. 63, NO. 10, pp. 583-584.